对发表于《葡萄牙医学学报》2021年1月；34(1):35 - 46的文章“新冠病毒感染止血障碍评估中的粘弹性测试”的勘误
Correction to the article "Viscoelastic Tests in the Evaluation of Haemostatic Disorders in SARS-CoV-2 Infection", Published on Acta Med Port 2021 Jan;34(1):35-46.
作者信息
Rodrigues Anabela, Seara Sevivas Teresa, Leal Pereira Carla, Caiado André, Robalo Nunes António
机构信息
Serviço de Imuno-hemoterapia. Hospital Santa Maria. Centro Hospitalar de Lisboa Norte. Lisboa. Portugal.
Serviço de Sangue e Medicina Transfusional. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal.
出版信息
Acta Med Port. 2021 Jan 4;34(1):68. doi: 10.20344/amp.15487.
On page 36, in the fifth sentence of right-side column, where it reads: "Direct thrombin inhibitors (DTI) (argatroban, bivalirrubin) are used in COVID-19 infected patients with significantly lower antithrombin levels,24 or if heparin induced thrombocytopenia (HIT) occurs."It should read: "Direct thrombin inhibitors (DTI) (argatroban, bivalirudin) are used in COVID-19 infected patients with significantly lower antithrombin levels,24 or if heparin induced thrombocytopenia (HIT) occurs."Article published with errors: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/14784.
在第36页右侧栏的第五句中，原文为：“直接凝血酶抑制剂（DTI）（阿加曲班、比伐卢定）用于抗凝血酶水平显著降低的COVID-19感染患者，24或者如果发生肝素诱导的血小板减少症（HIT）。” 应改为：“直接凝血酶抑制剂（DTI）（阿加曲班、比伐芦定）用于抗凝血酶水平显著降低的COVID-19感染患者，24或者如果发生肝素诱导的血小板减少症（HIT）。”发表有误的文章链接：https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/14784 。
Zotero 插件